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Articles

Associations of ambient coarse particulate matter, nitrogen
dioxide, and carbon monoxide with the risk of kidney
disease: a cohort study
Benjamin Bowe, Yan Xie, Tingting Li, Yan Yan, Hong Xian, Ziyad Al-Aly

Summary

Background Experimental evidence and preliminary clinical evidence suggest that environmental air pollution
adversely effects kidney health. Previous work has examined the association between fine particulate matter and risk
of kidney disease; however, the association between ambient coarse particulate matter (PM10; ≤10 µm in aerodynamic
diameter), nitrogen dioxide (NO2), and carbon monoxide (CO) and risk of incident chronic kidney disease, chronic
kidney disease progression, and end-stage renal disease is not clear.
Methods We merged multiple large databases, including those of the Environmental Protection Agency and the
Department of Veterans Affairs, to build a cohort of US veterans, and used survival models to evaluate the association
between PM10, NO2, and CO concentrations and risk of incident estimated glomerular filtration rate (eGFR) of less
than 60 mL/min per 1·73 m², incident chronic kidney disease, eGFR decline of 30% or more, and end-stage renal
disease. We treated exposure as time-varying when it was updated annually and as cohort participants moved.
Findings Between Oct 1, 2003, and Sept 30, 2012, 2 010 398 cohort participants were followed up over a median of
8·52 years (IQR 8·05–8·80). An increased risk of eGFR of less than 60 mL/min per 1·73 m² was associated with an
IQR increase in concentrations of PM10 (hazard ratio 1·07, 95% CI 1·06–1·08), NO2 (1·09, 1·08–1·10), and CO (1·09,
1·08–1·10). An increased risk of incident chronic kidney disease was associated with an IQR increase in concentrations
of PM10 (1·07, 1·05–1·08), NO2 (1·09, 1·08–1·11), and CO (1·10, 1·08–1·11). An increased risk of an eGFR decline
of 30% or more was associated with an IQR increase in concentrations of PM10 (1·08, 1·07–1·09), NO2 (1·12,
1·10–1·13), and CO (1·09, 1·08–1·10). An increased risk of end-stage renal disease was associated with an IQR
increase in concentrations of PM10 (1·09, 1·06–1·12), NO2 (1·09, 1·06–1·12), and CO (1·05, 1·02–1·08). Spline
analyses suggested a monotonic increasing association between PM10, NO2, and CO concentrations and risk of kidney
outcomes.
Interpretation Environmental exposure to higher concentrations of PM10, NO2, and CO is associated with increased
risk of incident chronic kidney disease, eGFR decline, and end-stage renal disease.
Funding US Department of Veterans Affairs.
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.

Introduction
Experimental evidence and observations from several
small clinical research studies suggest that exposure to
higher amounts of air pollution adversely affects kidney
function. Higher kidney disease mortality in coal mining
regions of the Appalachian Mountains (USA) has been
ascribed to environmental exposure to air pollutants.1
Residential proximity to major roads, which in large part
is an indirect measure of exposure to air pollutants (and
other possible factors, including noise pollution), is
associated with a reduced estimated glomerular filtration
rate (eGFR).2 In a large cohort of US veterans,3 higher
amounts of fine particulate matter were associated with
increased risk of incident chronic kidney disease, eGFR
decline, and end-stage renal disease.
Major air pollutants include fine particulate matter of
smaller than 2·5 µm in aerodynamic diameter (PM2·5),
coarse particulate matter of smaller than 10 µm in
www.thelancet.com/planetary-health Vol 1 October 2017
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aerodynamic diameter (PM10), nitrogen dioxide (NO2),
carbon monoxide (CO), and others. Previous work has
focused on the evaluation of the association between PM2·5
and kidney disease outcomes.3 Much less is known about
the association of other major pollutants and the risk of
development of kidney disease and kidney function decline.
Identification of specific air pollutants as potential
drivers of adverse kidney outcomes might inform targeted
mitigation strategies and will possibly contribute to the
national and global discussion on the importance of
curbing air pollution on health and disease. We aimed to
investigate whether exposure to higher amounts of air
pollutants, including PM10, NO2, and CO, is associated with
increased risk of development and progression of kidney
disease. To address this question, we built a national cohort
of US veterans and followed up these veterans to examine
the association between PM10, NO2, and CO and risk of
incident eGFR of less than 60 mL/min per 1·73 m²,
e267
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Research in context
Evidence before this study
Experimental and epidemiological evidence suggests that
environmental exposure to fine particulate matter smaller than
2·5 µm in aerodynamic diameter adversely effects kidney
function. The associations between other major air pollutants,
including ambient coarse particulate matter (PM10), nitrogen
dioxide (NO2), and carbon monoxide (CO), and the risk of incident
chronic kidney disease, chronic kidney disease progression, and
end-stage renal disease have not been previously investigated.
Added value of this study
This Article provides evidence that higher concentrations of
PM10, NO2, and CO are associated with increased risk of chronic
kidney disease development, kidney function decline, and
end-stage renal disease. The findings show a monotonic
increasing association between exposure concentrations of
PM10, NO2, and CO and risk of adverse kidney outcomes. The
study also provides a quantitative assessment of the burden of
incident kidney disease and incident end-stage renal disease
attributable to PM10, NO2, and CO in the USA.

incident chronic kidney disease, eGFR decline of 30% or
more, and end-stage renal disease.
For more on the CDC CKD
Surveillance Project see http://
www.cdc.gov/ckd

For more on the County Health
Rankings’ dataset see http://
www.countyhealthrankings.org/
rankings/data
See Online for appendix

Methods

Study design and participants
We selected users of the Veterans Affairs Health Care
System from the US Department of Veterans Affairs’
datasets. Participants were required to have at least
one outpatient eGFR measurement between Oct 1, 2003,
and Sept 30, 2004, and no previous history of end-stage
renal disease; the date of the last eGFR measurement in
this time period was designated as time zero (T0;
n=2 751 717). We further selected participants who had at
least one outpatient eGFR measurement after T0
(n=2 680 431), and followed up these participants until
Sept 30, 2012, or death. We then limited participants to
those individuals who at any timepoint during follow-up
were within 48 km of an air monitoring station that
measured at least one of the studied pollutants, yielding
a final cohort of 2 010 398. The study was approved by the
Institutional Review Board of the Veterans Affairs Saint
Louis Health Care System, Saint Louis, MO, USA.

Data sources

For more on the Environmental
Protection Agency’s annual air
quality data see http://www.
epa.gov/ttn/airs/aqsdatamart

e268

We used the Department of Veterans Affairs’ datasets to
procure participants’ demographics, inpatient and
outpatient data, laboratory information, vital signs, and
prescriptions. We obtained zip code and county of
residence at time of receipt of care from inpatient and
outpatient encounter data. Data from the US Renal
Database System (USRDS) were used to augment endstage renal disease status information.4–10 Environmental
Protection Agency’s (EPA) annual air quality data
from 2003 to 2012, provided data on all pollutants and

Implications of all the available evidence
The findings suggest that elevated concentrations of ambient
PM10, NO2, and CO are important, yet unrecognised,
environmental risk factors for kidney disease and its
progression. The results will also inform estimates of the
global burden of kidney disease attributable to air pollution,
and serve to inform policy makers and the public about the
hazards of specific pollutants on the kidneys. The findings
might explain some of the geographical variation in the
burden of kidney disease in the USA and globally. Since the
burden of kidney disease of unknown origin is increasing in
multiple geographies worldwide, especially those countries
with significant air pollution from agricultural sources, this
report might serve as a blueprint to investigate the
contribution of air pollution to this rising—so far elusive—
disease entity when identification of specific air pollutants as
potential drivers of adverse kidney outcomes might inform
targeted mitigation strategies.

the latitude and longitude of the data’s corresponding
monitoring station collection points. National US
estimates of the incident rates of chronic kidney disease
were obtained from the CDC CKD Surveillance Project
and treated end-stage renal disease were obtained from
the 2016 USRDS Annual Data Report.11 We obtained
county-level data on metropolitan statistical areas
(MSA), zip code centroid, population, population
density, and poverty from the US Census Bureau. We
used data from the 2014 County Health Rankings’
dataset to obtain information on county-level
variables.12,13 A more detailed description of data sources
is provided in the appendix.

Exposure assessment
The primary predictor variables for analyses were annual
mean concentrations of 24-h local condition particulate
matter of 10 μm or smaller in aerodynamic diameter
(μg/m³), 1-h observed NO2 (parts per billion [ppb]), and
8-h running average CO (parts per million [ppm]).
Participants were assigned exposure, as time-varying, on
the basis of the nearest air monitoring station, within
48 km, to the centroid of the participant’s zip code of
residence. Air monitoring station measures were selected
for inclusion in these analyses when they met EPA quality
control conditions of completeness and certification, as
appropriate. We assessed distance from the air monitoring
station to the participant’s residential zip code’s centroid
with the haversine formula. We assigned cohort
participants’ geographical location, which might have
varied over time, on the basis that their zip code contained
in outpatient or inpatient data closest, but before, a given
timepoint. Pollutant exposure was updated as cohort
participants moved, in which average annual exposure
www.thelancet.com/planetary-health Vol 1 October 2017
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was matched to their updated geographical locations at
any specific time. In all primary analyses, unless
otherwise indicated, measures correspond to an IQR
increase in the pollutant.

Ascertainment of outcomes
Outcomes were comprised of the risk of incident eGFR
of less than 60 mL/min per 1·73 m²; the risk of incident
chronic kidney disease, with chronic kidney disease
defined as two eGFR measurements less than 60 mL/min
per 1·73 m² at least 90 days apart and time of event was
set at the second eGFR measurement;6 time until a
decline of eGFR of 30% or more from eGFR at T0; and
time until end-stage renal disease.14 Participants were
censored following inception of end-stage renal disease,
for all outcomes other than end-stage renal disease, and
at time of death or end of study follow-up. We determined
the date of first end-stage renal disease service (dialysis
or kidney transplant) by linking the databases of the
Department of Veterans Affairs and USRDS. Outpatient
eGFR measurements were used in the evaluation of all
outcomes except for end-stage renal disease, in which
inpatient eGFR data were also used. We estimated eGFR
using the four-variable abbreviated Chronic Kidney
Disease Epidemiology Collaboration (CKD-EPI) equation
on the basis of age, race, sex, and serum creatinine
concentrations.15

Covariates
We based covariate selection on factors that could
conceivably confound the association of air pollutants
and kidney disease outcomes, and this assessment was
informed by previous studies.4,12,16–19 Baseline covariates
were ascertained from Oct 1, 1999, until cohort entry (T0).
Covariates included age, race, sex, cancer, cardiovascular
disease, chronic lung disease, diabetes mellitus,
hyperlipidaemia, hypertension, T0 eGFR, body-mass
index, smoking status, use of angiotensin-converting
enzyme inhibitors or angiotensin receptor blockers,
number of outpatient eGFR measurements, number of
hospital admissions, county population density, and
percentage of the county in poverty. Details of covariate
definitions are presented in the appendix. We treated
covariates as continuous variables when relevant, unless
otherwise indicated.

Statistical analysis
Demographic and clinical characteristics of the overall
cohort are presented as frequency (percentage) for
categorical variables, and as mean (SD) or median (IQR)
for continuous variables. We present the distribution of
pollutants in the cohort in 2004, and the IQRs were used
in subsequent analyses. Age, race, sex, and eGFRadjusted incidence of each adverse kidney outcome are
presented by pollutant category, in which categories are
defined as less than the 25th percentile for category 1,
25–75th percentile for category 2, and more than the
www.thelancet.com/planetary-health Vol 1 October 2017

75th percentile for category 3. We used Cox proportional
hazards survival models to assess the association
between pollutants, as a time-varying exposure, and
outcomes, and adjusted for covariates. We used a robust
sandwich variance estimator to account for intra-county
correlation. As the exposure definition was dependent
on proximity to an air monitoring station, patients were
not included in analyses at time t if, at time t, they were
not within 48 km of an air monitoring station measuring
the pollutant of interest; participants were included at all
other times as appropriate. Additionally, we did analyses
with exposure defined by pollutant category, as previously
defined. Restricted cubic spline analyses were
undertaken,20 and we included distribution histograms
of the pollutants in the background of these graphs
(appendix). We analysed exposure to assess within-city
effects in those participants who lived within 8 km of an
air monitoring station, in which city was defined by
MSA, using a within-city model with a city-wide mean
parameter (for between-city effects) and a difference
from city mean parameter (for within-city effects;
appendix).16 As a negative control,21,22 we examined the
association of sodium concentration, in which exposure
was assigned in the same method as that of the primary
pollutants of interest, with kidney disease outcomes, and
also with mortality.
Population attributable fractions (PAFs) are presented
as a measure of the proportion of the outcome in the
population attributable to each air pollutant exposure
above the theoretical minimum exposure risk level
(TMREL), and a PAF was additionally calculated for the
joint effect of the three pollutants to account for possible
overlap in effect.23,24 For all pollutants, we used the
fifth percentile of the distribution of all air monitoring
stations nationally in 2004, intended to be representative
of a realistically obtainable low pollutant amount, as the
TMREL, and any exposure amount under the TMREL
was considered not to contribute any risk. We calculated
PAF with the exposure distribution at T0 (appendix). We
calculated attributable burden of disease for incident
eGFR of less than 60 mL/min per 1·73 m² and end-stage
renal disease (appendix).11,25
We did not impute missing data. In analyses, a 95% CI
of a hazard ratio (HR) that did not include unity was
considered statistically significant. In all analyses, a
p value of 0·05 or less was considered statistically
significant. All statistical analyses were done using SAS
Enterprise Guide version 7.1. To test the robustness of the
study findings, we undertook a number of sensitivity
analyses (appendix).

Role of the funding source
The funder of this study had no role in study design, data
collection, data analysis, data interpretation, or writing of
the report. The corresponding author had full access to
all the data in the study and had final responsibility for
the decision to submit for publication.
e269
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Results
Between Oct 1, 2003, and Sept 30, 2012, 2 010 398 cohort
participants were followed up for a median of 8·52 years
(IQR 8·05–8·80; figure 1). Overall, cohort participants
were mostly white and male (table 1). In 2004, among
those individuals in the cohort, the median concentration
for PM10 was 20·45 μg/m³ (IQR 14·64–24·81), NO2 was
14·54 ppb (9·69–17·91), and CO was 0·51 ppm
(0·40–0·64). Adjusted incident rate of eGFR of
60 mL/min per 1·73 m², chronic kidney disease, eGFR
decline of 30% or more, and end-stage renal disease
gradually increased across ordinal categories of
increasing PM10, NO2, and CO concentrations (figure 2,
appendix).
In a cohort of participants who had no history of eGFR
of less than 60 mL/min per 1·73 m² before time of cohort
entry, an IQR increase in concentrations of PM10
(10·17 μg/m³), NO2 (8·22 ppb), and CO (0·24 ppm) was
associated with an increased risk of eGFR of less than
60 mL/min per 1·73 m² (table 2). Spline analyses
suggested a monotonic increasing association between
PM10, NO2, and CO concentrations and risk incident
eGFR of less than 60 mL/min per 1·73 m² (figure 3).
Because variation in regional characteristics might
confound the association between environmental air
pollutants and kidney disease, we developed analyses to
estimate risk within a city (appendix). Results of the
within-city models suggested that higher concentrations
of PM10, NO2, and CO within the same MSA were
associated with an increased risk of eGFR of less than
60 mL/min per 1·73 m² (table 3).
We assessed the risk of incident chronic kidney disease
in a subcohort of participants with no less than two eGFR
measurements separated by at least 90 days during
follow-up and no history of eGFR less than 60 mL/min
A

per 1·73 m² before time of cohort entry. The results were
consistent with the results showing an increased risk of
eGFR less than 60 mL/min in that an IQR increase in
concentrations of PM10, NO2, and CO was associated with
an increased risk of incident chronic kid
ney disease
(table 2). Spline analyses showed a monotonic increasing
association between concentrations of PM10, NO2, and
CO and risk of incident chronic kidney disease (figure 3).
Results of the within-city models suggested that higher
concentrations of PM10, NO2, and CO within the same
MSA were associated with an increased risk of incident
chronic kidney disease (table 3).
Overall cohort
Zip codes

22 098

Participants

2 010 398

Age (years)

62·15 (54·39–71·72)

Race
White

1 623 247 (80·74%)

Black

315 025 (15·67%)

Other

72 126 (3·59%)

Sex
Male

1 909 206 (94·97)
101 192 (5·03%)

Female
Cancer

235 223 (11·70%)

Cardiovascular disease

589 321 (29·31%)

Chronic lung disease

381 764 (18·99%)

Diabetes mellitus

559 470 (27·83%)

Hyperlipidaemia

1 134 687 (56·44%)

Hypertension

1 342 771 (66·79%)

Peripheral artery disease

52 968 (2·63%)

Smoking status
Current

516 116 (25·67%)

Former

435 632 (21·67%)

Never

1 058 650 (52·66%)

Body-mass index
2 751 717 participants with at least one eGFR measurement between
Oct 1, 2003, and Sept 30, 2004, and with no previous history of
end-stage renal disease, dialysis, or kidney transplant

2 680 431 participants with at least one eGFR measurement subsequent to T0

Underweight

20 990 (1·04%)

Normal weight
Overweight

791 783 (39·38%)

Obese

798 223 (39·70%)

ACEI or ARB use
Follow-up time (years)
eGFR at T0 (mL/min per 1·73 m²)

2 010 398 participants within 48 km of an air monitoring station that
measures a pollutant of interest at any time during follow-up

B
Assessment of
baseline covariates
up to T0

October,
1999

October, T0 September,
2003
2004

e270

Before T0

4 (2–7)
13 (8–20)

Population density (per km²)

Figure 1: Study design
(A) Flow diagram of cohort participant inclusion. (B) Data assessment timeline.
eGFR=estimated glomerular filtration rate. T0=time zero.

8·52 (8·05–8·80)
76·52 (20·06)

After T0

Percentage of county in poverty

September,
2012

936 555 (46·59%)

Number of outpatient eGFR measurements

Participants with one or more hospital
admissions

Annual average pollutant
concentration varying by
year after T0

399 402 (19·87%)

338 857 (16·86%)
12·7 (10·1–15·3)
138·4 (44·1–447·1)

Data are n, median (IQR), n (%), or mean (SD). Covariates were measured at T0,
unless otherwise stated. ACEI=angiotensin-converting enzyme inhibitors.
ARB=angiotensin receptor blockers. eGFR=estimated glomerular filtration rate.
T0=time zero.

Table 1: Characteristics of overall study cohort

www.thelancet.com/planetary-health Vol 1 October 2017
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Incident eGFR <60 mL/min per 1·73 m2

Incident rate (per 100 000 person-years)

8400
8100

Incident chronic kidney disease
4500

Category 1
Category 2
Category 3

4300

7800

4100

7500

3900

7200

3700

6900

3500

6600

3300

6300

3100

Incident rate (per 100 000 person-years)

eGFR decline ≥30%

End-stage renal disease

5350

60

5100

55

4850

50

4600

45

4350

40

4100

35

3850

30

3600

PM10

NO2

CO

25

PM10

NO2

CO

Pollutant

Pollutant

Figure 2: Adjusted incident rates of kidney disease outcomes by pollutant category
Adjusted for age, race, sex, and T0 eGFR. Categories are defined by the cohort distribution in 2004: less than the 25th percentile is category 1, 25–75th percentile is
category 2, and more than the 75th percentile is category 3. Error bars represent 95% CIs. T0=time zero. eGFR=estimated glomerular filtration rate. CO=carbon
monoxide. NO2=nitrogen dioxide. PM10=ambient course particulate matter (≤10 μm).

An IQR increase in PM10, NO2, and CO concentrations
was associated with increased risk of eGFR decline
of 30% or more (table 2). Spline analyses suggested a
monotonic increasing association between PM10, NO2,
and CO concentrations and risk of eGFR decline of 30%
or more (figure 3). Risk estimates from within-city
analyses showed an association of PM10, NO2, and CO
with eGFR decline of 30% or more (table 3). The results
were consistent in analyses considering the outcome of
end-stage renal disease in that an IQR increase in
concentrations of PM10, NO2, and CO was associated with
an increased risk of end-stage renal disease (table 2).
Spline functions depicted a consistent monotonic
increasing association (figure 3). Risk estimates from
within-city analyses showed an association of PM10, NO2,
and CO with end-stage renal disease (table 3).
We considered exposure to ambient air sodium
concentration as a negative control. No biological or
clinical evidence supports an association between
www.thelancet.com/planetary-health Vol 1 October 2017

Incident eGFR
<60 mL/min
per 1·73 m²*

Incident chronic
kidney disease†

eGFR decline ≥30%

End-stage
renal disease

PM10

673 230; 1·07
(1·06–1·08)

674 905; 1·07
(1·05–1·08)

964 688; 1·08
(1·07–1·09)

1 034 488; 1·09
(1·06–1·12)

NO2

983 744; 1·09
(1·08–1·10)

958 051; 1·09
(1·08–1·11)

1 426 272; 1·12
(1·10–1·13)

1 452 755; 1·09
(1·06–1·12)

CO

1 029 175; 1·09
(1·08–1·10)

997 700; 1·10
(1·08–1·11)

1 490 023; 1·09
(1·08–1·10)

1 510 545; 1·05
(1·02–1·08)

Sodium

1 084 437; 0·99
(0·99–0·99)

1 053 333; 0·99
(0·98–0·99)

1 564 530; 0·99
(0·99–0·99)

1 588 470; 1·01
(1·00–1·01)

Data are n; hazard ratio (95% CI). Models are adjusted for baseline age, race, sex, T0 eGFR, hypertension, diabetes,
cancer, cardiovascular disease, chronic lung disease, body-mass index, smoking, angiotensin-converting enzyme
inhibitor and angiotensin receptor blocker use, number of hospital admissions, number of eGFR measurements,
county population density, and percentage of county in poverty. eGFR=estimated glomerular filtration rate.
PM10=ambient course particulate matter (≤10 μm). NO2=nitrogen dioxide. CO=carbon monoxide. T0=time zero.
*Incident eGFR of less than 60 mL/min per 1·73 m² was evaluated in a subcohort of people with no previous history of
eGFR less than 60 mL/min per 1·73 m² at the time of cohort entry. †Incident chronic kidney disease was evaluated in a
subcohort of people with at least two eGFR measurements taken at least 90 days apart and who had no previous
history of eGFR less than 60 mL/min per 1·73 m² at the time of cohort entry.

Table 2: Risk of kidney disease outcomes for every IQR increase in air pollutant and sodium concentration
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A
2·2

15

1·6
Incident eGFR
<60 mL/min
per 1·73 m2

1·4
1·2
1·0

10
5

0·8

0

2·2

eGFR decline ≥30%

End-stage
renal disease

2·0

20
15

1·6
1·4

10

1·2

Percentage

1·8
HR

20
Percentage

1·8
HR

Incident chronic
kidney disease

HR
95% CI
Probability distribution

2·0

5

1·0
0·8

0·2

0·4

0·6

0·8

1·0

0·2

0·4

0·6

CO (ppm)

0·8

0

1·0

CO (ppm)

B
1·6

15

HR

1·0

5

0·8

0

1·6

15

HR

1·4
eGFR decline ≥30%

1·2

10

End-stage
renal disease

5

1·0
0·8

5

10

15

20

25

30

5

10

15

NO2 (ppb)

20

25

30

0

NO2 (ppb)

C
Incident eGFR
<60 mL/min
per 1·73 m2

2·0

HR

1·8

Incident chronic
kidney disease

12·5

1·6

10·0

1·4

7·5

1·2

5·0

1·0

2·5

0·8

0
eGFR decline ≥30%

2·0

End-stage
renal disease

1·8

15·0
12·5

1·6

10·0

1·4

7·5

1·2

5·0

1·0

2·5

0·8

5

10

15

20

25
PM10 (μg/m3)

30

35

40

5

10

15

20

25

30

35

40

Percentage

HR

15·0

Percentage
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10

Percentage

Figure 3: Spline analyses of
risk of kidney outcomes by
pollutant concentrations
with pollutant probability
distribution
Models are adjusted for age,
race, sex, cancer,
cardiovascular disease, chronic
lung disease, diabetes mellitus,
hyperlipidaemia,
hypertension, T0 eGFR, bodymass index, smoking,
angiotensin-converting
enzyme inhibitor or
angiotensin receptor blocker
use, county population
density, number of outpatient
eGFR measurements, number
of hospital admissions, and
percentage of the county in
poverty for CO (A), NO2 (B),
and PM10 (C). The minimum
pollutant concentration
included in analyses served as
the referent value. T0=time
zero. eGFR=estimated
glomerular filtration rate.
CO=carbon monoxide.
ppm=parts per million.
NO2=nitrogen dioxide.
ppb=parts per billion.
PM10=ambient course
particulate matter (≤10 μm).
HR=hazard ratio.

Incident chronic
kidney disease

Incident eGFR
<60 mL/min
per 1·73 m2

1·2

Percentage

1·4

0

PM10 (μg/m3)
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different sodium concentrations in the air and risk of
adverse kidney outcomes; thus, ambient air sodium is a
suitable negative control.22 We therefore tested the
association between ambient air sodium concentrations
and the risk of kidney outcomes, and the results indicated
no significant association (table 2). Air sodium
concentrations were not associated with the risk of death
(HR 1·00, 95% CI 1·00–1·01).
PAF represents the proportional reduction in population
disease that would occur if exposure to pollutants was
reduced to the TMREL. The PAFs of PM10, NO2, and CO
considered separately for each kidney disease outcome
are provided in table 4. In analyses in which the pollutants
were considered jointly, the PAF for each kidney disease
outcome exceeded that of any one pollutant alone (table 4).
The national burden of kidney disease attributable to
concentrations of PM10 exceeding the TMREL in the
contiguous USA was 340 757·4 incident cases (95% CI
283 964·5–397 550·2) of eGFR less than 60 mL/min
per 1·73 m² per year and 15 223·7 incident cases
(9674·8–20 772·7) of end-stage renal disease per year. The
national burden of kidney disease attributable to excess
NO2 was 366 297·3 incident cases (321 266·3–414 688·9)
of eGFR less than 60 mL/min per 1·73 m² per year and
12 796·1 incident cases (8490·9–17 101·3) of end-stage
renal disease per year. Our estimate of the national
burden of kidney disease attributable to excess CO was
349 494·7 incident cases (308 160·2–390 829·2) of eGFR
less than 60 mL/min per 1·73 m² per year and 7091·7
incident cases (6613·3–7330·8) of end-stage renal disease
per year. When considered jointly, the national burden of
kidney disease attributable to PM10, NO2, and CO was
765 863·9 incident cases (656 982·9–875 081·0) of eGFR
less than 60 mL/min per 1·73 m² per year and 29 227·7
incident cases (19 899·7–38 855·7) of end-stage renal
disease per year.
To test the sensitivity of our results, we did the following
sensitivity analyses. We considered exposure in ordinal
categories. We observed a graded association in that the
risk was increased with increasing ordinal category;
compared with the lowest category, the highest category
of PM10, NO2, and CO was associated with increased risk
of kidney outcomes (appendix). To test different spatial
resolutions for exposure definition, exposure levels were
assigned by nearest air monitoring station within 8 km
and 16 km (appendix); the results were consistent in that
an IQR increase in exposure to pollutants (PM10, NO2, and
CO) was associated with significant increased risk of
kidney outcomes. To account for local conditions that
might confound the association of PM10, NO2, and CO and
risk of kidney outcomes,12 we also did analyses in which
we controlled for several US county-level characteristics
(in several domains capturing health outcomes, health
behaviours, clinical care, social and economic factors,
physical environment, and demographics) obtained from
the County Health Ranking’s dataset (appendix),13 and
results were consistent in that an IQR increase in
www.thelancet.com/planetary-health Vol 1 October 2017

Incident eGFR
<60 mL/min
per 1·73 m²*

Incident chronic
kidney disease†

eGFR decline
≥30%

End-stage renal
disease

PM10
Sample size

593 101

844 356

912 032

Between-city difference

589 691
1·44
(1·34–1·54)

1·32
(1·21–1·44)

1·40
(1·30–1·50)

1·62
(1·36–1·94)

Within-city difference

1·06
(1·05–1·08)

1·06
(1·05–1·08)

1·07
(1·06–1·08)

1·09
(1·05–1·12)

NO2
Sample size

932 504

907 188

1 351 258

1 375 128

Between-city difference

1·29
(1·24–1·34)

1·32
(1·26–1·39)

1·31
(1·25–1·36)

1·28
(1·16–1·42)

Within-city difference

1·07
(1·06–1·08)

1·07
(1·05–1·09)

1·10
(1·08–1·11)

1·06
(1·03–1·10)

CO
Sample size

985 200

1 426 391

1 445 056

Between-city difference

1·10
(1·09–1·11)

954 656
1·11
(1·09–1·12)

1·10
(1·09–1·11)

1·05
(1·02–1·08)

Within-city difference

1·09
(1·08–1·10)

1·10
(1·08–1·11)

1·09
(1·08–1·10)

1·04
(1·02–1·07)

Data are n or hazard ratio (95% CI). Models are adjusted for baseline age, race, sex, T0 eGFR, hypertension, diabetes,
cancer, cardiovascular disease, chronic lung disease, body-mass index, smoking, angiotensin-converting enzyme
inhibitor and angiotensin receptor blocker use, number of hospital admissions, number of eGFR measurements, county
population density, and percentage of county in poverty. eGFR=estimated glomerular filtration rate. PM10=ambient
course particulate matter (≤10 μm). NO2=nitrogen dioxide. CO=carbon monoxide. T0=time zero. *Incident eGFR of less
than 60 mL/min per 1·73 m² was evaluated in a subcohort of people with no previous history of eGFR less than
60 mL/min per 1·73 m² at the time of cohort entry. †Incident chronic kidney disease was evaluated in a subcohort of
people with at least two eGFR measurements taken at least 90 days apart and who had no previous history of eGFR less
than 60 mL/min per 1·73 m² at the time of cohort entry.

Table 3: Risk of kidney outcomes for every IQR increase in pollutant concentration for between-city
and within-city analyses

exposure to pollutants was associated with an increased
risk of kidney outcomes. We then considered additional
kidney outcomes of doubling of serum creatinine
concentrations and the composite outcome of end-stage
renal disease or eGFR decline of 50% or more, and the
results were consistent (appendix).
We examined the association of PM10, NO2, and CO and
risk of death. This analysis served as a positive control in
which a-priori observations suggested that an association
is expected.25,26 Our results showed a significant association
between PM10, NO2, and CO concentrations and risk of
death (appendix). Results of sensitivity analyses for the
competing risk of death were consistent with those shown
in primary analyses27 (appendix).

Discussion
In this study, we aimed to characterise the association
between ambient concentrations of PM10, NO2, and CO
and risk of incident chronic kidney disease, eGFR decline
of 30% or more, and end-stage renal disease. The results
suggest a consistent graded and monotonically increasing
association in which exposure to higher concentrations
of these pollutants is associated with increased risk of
development of kidney disease and progression to endstage renal disease. The results were consistent across a
range of kidney outcomes, and were robust to challenges
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Theoretical minimum Incident eGFR <60 mL/min Incident chronic kidney
per 1·73 m² (%)*
disease (%)†
risk exposure
concentration

eGFR decline ≥30% (%)

End-stage renal disease (%)

PM10

4·56 μg/m³

10·14 (8·45–11·83)

9·97 (7·96–11·98)

11·62 (9·88–13·36)

12·73 (8·09–17·37)

NO2

3·09 ppb

10·90 (9·56–12·34)

10·99 (9·25–12·73)

13·70 (12·22–15·19)

10·70 (7·10–14·30)

CO
Joint effect‡

0·18 ppm
PM10 4·56 μg/m³,
NO2 3·09 ppb,
and CO 0·18 ppm

10·40 (9·17–11·63)
265 206; 22·79
(19·55–26·04)

11·37 (9·83–12·91)
253 095; 23·91
(20·10–27·71)

10·68 (9·43–11·93)
381 379; 23·94
(20·62–27·26)

5·93 (5·53–6·13)
381 379; 24·44
(16·64–32·24)

Data are HR (95% CI) or n; HR (95% CI). Models are adjusted for baseline age, race, sex, T0 eGFR, hypertension, diabetes, cancer, cardiovascular disease, chronic lung disease,
body-mass index, smoking, angiotensin-converting enzyme inhibitor and angiotensin receptor blocker use, number of hospital admissions, number of eGFR measurements,
county population density, and percentage of county in poverty. eGFR=estimated glomerular filtration rate. PM10=ambient course particulate matter (≤10 μm). NO2=nitrogen
dioxide. ppb=parts per billion. CO=carbon monoxide. ppm=parts per million. HR=hazard ratio. T0=time zero. *Incident eGFR of less than 60 mL/min per 1·73 m² was evaluated
in a subcohort of people with no previous history of eGFR less than 60 mL/min per 1·73 m² at the time of cohort entry. †Incident chronic kidney disease was evaluated in a
subcohort of people with at least two eGFR measurements taken at least 90 days apart and who had no previous history of eGFR less than 60 mL/min per 1·73 m² at the time
of cohort entry. ‡Done in participants who were within 48 km of stations measuring the three pollutants.

Table 4: Population attributable fraction for kidney outcomes by air pollutant

in sensitivity analyses, including analyses which
considered exposure in ordinal categories, varying spatial
resolution for exposure definition, and—to account for
potential regional variation—within-city estimates. Our
analytic strategies also included testing a negative
control, which showed that ambient air sodium
concentrations (routinely collected by air monitoring
stations) were not associated with higher risk of adverse
kidney outcomes. Taken together, the findings suggest
that environmental exposure to elevated concentrations
of PM10, NO2, and CO is a novel risk factor for the
development and progression of kidney disease.
Few experimental and clinical studies1,2,12,28–36 have
examined the effect of environmental air pollution on the
kidney. Air pollution has been cited as a potential
explanation of the geographical variation in burden of
kidney disease in the USA, Europe, and globally.12,34–36 We
previously observed clusters of geographical areas in
the USA with high prevalence for increased odds of rapid
eGFR decline that were not explained by traditional
drivers, including diabetes mellitus and hypertension.
Our report on the association between specific air
pollutants (PM10, NO2, and CO) and risk of kidney
outcomes might explain some of these geographical
disparities in the USA, can inform targeted mitigation
strategies, and, most importantly, contributes to the
broader national and global discussion on the hazardous
effect of air pollution on kidney health.
We used the Global Burden of Disease methodologies
and developed analyses to estimate the national burden of
disease attributable to excess concentrations of
environmental air pollutants including PM10, NO2, and
CO.23,25,37,38 The findings provide a quantitative assessment—
to inform the public and policy makers—of the potential
reduction in the burden of kidney disease that is likely to
be achievable with targeted reduction of specific
environmental pollutants. These estimates might also
inform global estimates of the burden of kidney disease
attributable to excess concentrations of PM10, NO2, and CO.
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The biological mechanism or mechanisms
underpinning the reported associations is not entirely
clear. Several hypotheses have been proposed to
explain the extrapulmonary effects of air pollution.
One hypothesis suggests that inhaled pollutants might
lead to pulmonary inflammation, which could then
trigger systemic inflammation. The second hypothesis
posits that pollutants might provoke the lung
autonomic nervous system. The third (and most
widely accepted) hypothesis postulates that air
pollutants might traverse the alveolar space and enter
the bloodstream where they can produce an untoward
effect on remote organs.31,39–51
Our study has a number of limitations. Our cohort
included US veterans who were mostly older, white men;
therefore, the findings might not be generalisable to
other populations. We accounted for known confounders,
but cannot exclude the possibility of residual confounding
(either unmeasured or unknown). Our datasets did not
contain information on time spent in traffic or outdoors,
which can result in misclassification of exposure.
The study has a number of strengths. We built a large
national cohort of US veterans (17 128 591 person-years)
who are recipients of care in a single integrated network
of health-care systems. Our analytic strategies included
the use of time-varying exposure (to reflect changes in
concentrations of exposure with time and as participants
moved from one area to another). We evaluated a range
of well defined chronic kidney outcomes across the
continuum of the chronic kidney disease evolution
spectrum, including the development of chronic kidney
disease (incident eGFR <60 mL/min per 1·73 m² and
incident chronic kidney disease), chronic kidney disease
progression (eGFR decline >30%), and the terminal
outcome of end-stage renal disease. We tested the
robustness of the results in multiple sensitivity analyses
including within-city analyses, which reduces concern
about confounding due to variation in regional
characteristics. Finally, we applied both a positive control
www.thelancet.com/planetary-health Vol 1 October 2017
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and a negative control. In summary, our results show a
significant association between concentrations of PM10,
NO2, and CO and risk of development of kidney disease,
and its progression to end-stage renal disease. The
national burden of kidney disease attributable to these
pollutants is not trivial and an effort to improve air
quality might alleviate the burden of kidney disease in
the USA and globally.
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